Gene Therapy for SCID Market Insights: Key Players, Vector Technologies, and Commercial Strategies
The global gene therapy for SCID market is witnessing strong momentum as advancements in genetic engineering and cellular therapies reshape treatment pathways for rare immunodeficiency disorders. According to projections, the market is expected to expand at a robust compound annual growth rate (CAGR) and could reach a valuation of US$ 2.0 billion by 2034, reflecting the growing adoption of...
0 Condivisioni
488 Visualizzazioni